Genetic factors and pathogenesis of waldenström's macroglobulinemia

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Waldenström's macroglobulinemia (WM) is an indolent but incurable B-cell malignancy. Over the last decade, advances in the molecular field brought about by the use of high-throughput genomic analyses - including array-based comparative genomic hybridization and massively parallel genome sequencing - have considerably improved our understanding of the genetic basis of WM. Its pathogenesis, however, remains fragmented. Important steps have been made in elucidating the underlying aberrations and deregulated mechanisms of the disease, and thereby providing invaluable information for identifying biomarkers for disease diagnosis, risk stratification, and therapeutic approaches. We review the genetic basis of the disease.

Original languageEnglish (US)
Pages (from-to)450-456
Number of pages7
JournalCurrent Oncology Reports
Volume15
Issue number5
DOIs
StatePublished - Oct 2013

Fingerprint

Waldenstrom Macroglobulinemia
High-Throughput Nucleotide Sequencing
Inborn Genetic Diseases
Comparative Genomic Hybridization
B-Lymphocytes
Biomarkers
Genome
Neoplasms
Therapeutics

Keywords

  • Array-based comparative genomic hybridization
  • Genetics
  • Massively parallel DNA sequencing
  • MYD88
  • Waldenström's macroglobulinemia

ASJC Scopus subject areas

  • Oncology

Cite this

Genetic factors and pathogenesis of waldenström's macroglobulinemia. / Monge, Jorge; Braggio, Esteban D; Ansell, Stephen Maxted.

In: Current Oncology Reports, Vol. 15, No. 5, 10.2013, p. 450-456.

Research output: Contribution to journalArticle

@article{31327aaad4e44e44b2d6db49be75b73b,
title = "Genetic factors and pathogenesis of waldenstr{\"o}m's macroglobulinemia",
abstract = "Waldenstr{\"o}m's macroglobulinemia (WM) is an indolent but incurable B-cell malignancy. Over the last decade, advances in the molecular field brought about by the use of high-throughput genomic analyses - including array-based comparative genomic hybridization and massively parallel genome sequencing - have considerably improved our understanding of the genetic basis of WM. Its pathogenesis, however, remains fragmented. Important steps have been made in elucidating the underlying aberrations and deregulated mechanisms of the disease, and thereby providing invaluable information for identifying biomarkers for disease diagnosis, risk stratification, and therapeutic approaches. We review the genetic basis of the disease.",
keywords = "Array-based comparative genomic hybridization, Genetics, Massively parallel DNA sequencing, MYD88, Waldenstr{\"o}m's macroglobulinemia",
author = "Jorge Monge and Braggio, {Esteban D} and Ansell, {Stephen Maxted}",
year = "2013",
month = "10",
doi = "10.1007/s11912-013-0331-7",
language = "English (US)",
volume = "15",
pages = "450--456",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - Genetic factors and pathogenesis of waldenström's macroglobulinemia

AU - Monge, Jorge

AU - Braggio, Esteban D

AU - Ansell, Stephen Maxted

PY - 2013/10

Y1 - 2013/10

N2 - Waldenström's macroglobulinemia (WM) is an indolent but incurable B-cell malignancy. Over the last decade, advances in the molecular field brought about by the use of high-throughput genomic analyses - including array-based comparative genomic hybridization and massively parallel genome sequencing - have considerably improved our understanding of the genetic basis of WM. Its pathogenesis, however, remains fragmented. Important steps have been made in elucidating the underlying aberrations and deregulated mechanisms of the disease, and thereby providing invaluable information for identifying biomarkers for disease diagnosis, risk stratification, and therapeutic approaches. We review the genetic basis of the disease.

AB - Waldenström's macroglobulinemia (WM) is an indolent but incurable B-cell malignancy. Over the last decade, advances in the molecular field brought about by the use of high-throughput genomic analyses - including array-based comparative genomic hybridization and massively parallel genome sequencing - have considerably improved our understanding of the genetic basis of WM. Its pathogenesis, however, remains fragmented. Important steps have been made in elucidating the underlying aberrations and deregulated mechanisms of the disease, and thereby providing invaluable information for identifying biomarkers for disease diagnosis, risk stratification, and therapeutic approaches. We review the genetic basis of the disease.

KW - Array-based comparative genomic hybridization

KW - Genetics

KW - Massively parallel DNA sequencing

KW - MYD88

KW - Waldenström's macroglobulinemia

UR - http://www.scopus.com/inward/record.url?scp=84884597124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884597124&partnerID=8YFLogxK

U2 - 10.1007/s11912-013-0331-7

DO - 10.1007/s11912-013-0331-7

M3 - Article

VL - 15

SP - 450

EP - 456

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 5

ER -